Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland: A Structured Commentary

Clinical and Translational Neuroscience

doi 10.1177/2514183x18822073

Full Text

Abstract

Available in

Date

January 1, 2019

Authors

Publisher

SAGE Publications

Related search

Virus Specific Antibodies in Multiple Sclerosis.

English

Perspectives of People With Multiple Sclerosis About Helminth Immunotherapy

International Journal of MS Care

Specialized Nursing

English

BOOK REVIEWS: Neurobehavioral Aspects of Multiple Sclerosis.

Journal of Neurology, Neurosurgery and Psychiatry

English

New Insights Into the Burden and Costs of Multiple Sclerosis in Europe: Results for Switzerland

Multiple Sclerosis

English

T-Cell Based Immunotherapy in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

English

Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis

Frontiers in Neuroscience

English

Rehabilitation in Multiple Sclerosis: Commentary on the Recent AAN Systematic Review

Neurology: Clinical Practice

English

G1m1 Predominance of Intrathecal Virus-Specific Antibodies in Multiple Sclerosis

Annals of Clinical and Translational Neurology

English

No Evidence for Association of a European-Specific Chromosome 17 Inversion With Multiple Sclerosis

European Journal of Human Genetics

English